Interval Breast Cancers Versus Screen Detected Breast Cancers: A Retrospective Cohort Study

Abstract

Mammographic screening detects most breast cancers but there are still women diagnosed with breast cancer between annual mammograms. We aim to identify features that differentiate screen detected breast cancers from interval breast cancer. All screening mammograms (n=211,517) performed 7/1/2013-6/30/2020 at our institution were reviewed. Patients with breast cancer diagnosed within one year of screening were included and divided into two distinct groups: screen detected cancer group and interval cancer group. Characteristics in these groups were compared using the chi square test, fisher test, and student's T test. A total of 1,232 patients were included (mean age 64 +/- 11). Sensitivity of screening mammography was 92% (1,136 screen detected cancers, 96 interval cancers). Patient age, race, and personal history of breast cancer were similar between the groups (p > 0.05). Patients with interval cancers more often had dense breast tissue (75/96=78% versus 694/1136=61%, p < 0.001). Compared to screen detected cancers, interval cancers were more often primary tumor stage two or higher (41/96=43% versus 139/1136=12%, p < 0.001) and regional lymph node stage one or higher (21/96=22% versus 132/1136=12%, p=0.003). Interval cancers were more often triple negative (16/77=21% versus [48/813=6%], p < 0.001) with high Ki67 proliferation indices (28/45=62% versus 188/492=38%, p=0.002). Mammographic screening had high sensitivity for breast cancer detection (92%). Interval cancers were associated with dense breast tissue and had higher stage with less favorable molecular features compared to screen detected cancers.